The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKAPE.L Regulatory News (KAPE)

  • There is currently no data for KAPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison Investment Research Limited: Edison issues initiation on Kape Technologies (KAPE)

19 Jun 2018 14:25

Edison Investment Research Limited Edison Investment Research Limited: Edison issues initiation on Kape Technologies (KAPE) 19-Jun-2018 / 14:24 GMT/BST


London, UK, 19 June 2018

Edison issues initiation on Kape Technologies (KAPE)

Kape has made solid progress in refining its product set and is now fully focused on the consumer cyber security segment. By leveraging its marketing platform to scale new products while also transitioning to a subscription model, we expect to see strong revenue growth and margin expansion translating to our forecast 16% three year CAGR in EPS. With $69.5m net cash, acquisitions should enhance this further. We believe the shares should be on a growth rating yet despite the recent performance, the 21.8x FY18 P/E is below peers. We see upside towards 157p.

The B2C cyber security market is evolving rapidly to cope with the increased risk profile faced by consumers. In a competitive market, brand visibility and trust are key. While relatively small compared to large cyber security peers that offer similar product lines, Kape's experience in user acquisition should enable it to punch above its weight. A DCF suggests the share price is starting to discount the near-term organic opportunity. However, additional acquisitions are targeted and with net cash accounting for 41% of the market cap, a deal could trigger material earnings upside. With efficient deployment of the balance sheet, we see scope for the shares to move towards 157p as opportunities convert.Click here to view the full report.

All reports published by Edison are available to download free of charge from its websitewww.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Bridie Barrett, +44 (0)20 3077 5700Alasdair Young, +44 (0)20 3077 5758tech@edisongroup.comLearn more at www.edisongroup.com and connect with Edison on:LinkedIn https://www.linkedin.com/company/edison-investment-research Twitter www.twitter.com/Edison_Inv_ResYouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

696743 19-Jun-2018 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
16th Dec 20207:00 amRNSIssue of Equity
14th Dec 20207:00 amRNSCyberGhost Privacy Suite solution launched
6th Nov 20207:00 amRNSShare Repurchase/Directorate/Holdings in Company
3rd Nov 20203:47 pmRNSHolding(s) in Company
29th Oct 20204:49 pmRNSDirector Holdings in Company
29th Oct 20207:00 amRNSResult of Placing and Retail Offer
28th Oct 20204:54 pmRNSRetail Offer via PrimaryBid.com
28th Oct 20204:44 pmRNSProposed placing to raise US$100 million
25th Sep 20202:59 pmRNSBlocklisting Return
15th Sep 20207:00 amRNSHalf-year Results
14th Aug 20207:00 amRNSNotice of Results
21st Jul 20204:40 pmRNSSecond Price Monitoring Extn
21st Jul 20204:35 pmRNSPrice Monitoring Extension
21st Jul 20207:00 amRNSTrading Update
3rd Jul 202012:20 pmRNSTotal Voting Rights
25th Jun 20207:01 amRNSCapital Markets Event & Product Development Update
25th Jun 20207:00 amRNSDirector Dealing
11th Jun 20207:00 amRNSDirector Dealing
11th Jun 20207:00 amRNSCapital Markets Event
29th May 202012:18 pmRNSHolding(s) in Company
28th May 20204:37 pmRNSExercise of Options and Director Dealings
21st May 202012:36 pmRNSResult of AGM
21st May 20207:00 amRNSAGM Statement
1st May 202010:42 amRNSTotal Voting Rights
24th Apr 20207:00 amRNSPosting of Annual Report and Notice of AGM
2nd Apr 20203:15 pmRNSTotal Voting Rights
2nd Apr 20202:38 pmRNSDirector Dealing
31st Mar 20207:00 amRNSCOVID-19 Update
24th Mar 20204:43 pmRNSSecond Price Monitoring Extn
24th Mar 20204:39 pmRNSPrice Monitoring Extension
20th Mar 20209:05 amRNSSecond Price Monitoring Extn
20th Mar 20209:00 amRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSDirector Dealing
19th Mar 20207:00 amRNSNew Bank Facility
18th Mar 20204:41 pmRNSSecond Price Monitoring Extn
18th Mar 20204:36 pmRNSPrice Monitoring Extension
17th Mar 202011:05 amRNSSecond Price Monitoring Extn
17th Mar 202011:00 amRNSPrice Monitoring Extension
17th Mar 20207:00 amRNSFinal Results
13th Mar 202012:00 pmRNSBlock listing Interim Review
12th Mar 20204:42 pmRNSSecond Price Monitoring Extn
12th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Jan 20207:00 amRNSTrading Update & Notice of Results
16th Dec 20194:16 pmRNSTotal Voting Rights
16th Dec 20194:15 pmRNSDirector/PDMR Shareholding
13th Dec 20193:40 pmRNSCompletion of Private Internet Access Acquisition
21st Nov 20192:06 pmRNSSecond Price Monitoring Extn
21st Nov 20192:00 pmRNSPrice Monitoring Extension
20th Nov 20197:00 amRNSDirector Dealings
19th Nov 201911:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.